ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 948,79
-1,23%
Dow Jones
41 355,52
-1,33%
DAX
22 365,42
-1,07%
Brent Oil
69,815
1,12%
Bitcoin
80 762,61
2,93%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Telomir Pharmaceuticals Inc (TELO)

  7. Telomir Pharmaceuticals Inc (TELO) Actualités

TELO

Telomir Pharmaceuticals (TELO)

Telomir Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TELO
DateHeureSourceTitreSymboleSociété
03/03/202506h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TELOTelomir Pharmaceuticals Inc
25/02/202522h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TELOTelomir Pharmaceuticals Inc
14/02/202523h01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TELOTelomir Pharmaceuticals Inc
04/02/202522h45Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TELOTelomir Pharmaceuticals Inc
04/02/202522h05Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:TELOTelomir Pharmaceuticals Inc
25/11/202423h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TELOTelomir Pharmaceuticals Inc
12/11/202422h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TELOTelomir Pharmaceuticals Inc
12/08/202414h30GlobeNewswire Inc.Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher ChapmanNASDAQ:TELOTelomir Pharmaceuticals Inc
02/07/202414h30GlobeNewswire Inc.Telomir Pharmaceuticals Added to Membership of Russell 3000 and Russell Microcap IndexesNASDAQ:TELOTelomir Pharmaceuticals Inc
17/06/202422h10GlobeNewswire Inc.Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting PanelNASDAQ:TELOTelomir Pharmaceuticals Inc
30/05/202414h30GlobeNewswire Inc.Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1NASDAQ:TELOTelomir Pharmaceuticals Inc
24/05/202415h30GlobeNewswire Inc.New to The Street TV Announces Episode 575 with its Four Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV, Saturday, May 25, 2024, at 6:30 PM ETNASDAQ:TELOTelomir Pharmaceuticals Inc
16/05/202415h30GlobeNewswire Inc.Telomir Pharmaceuticals, Inc. Signs Media Deal with New to The Street for Network Interview Broadcasts, Billboards, and TV Commercial SupportNASDAQ:TELOTelomir Pharmaceuticals Inc
16/04/202414h30GlobeNewswire Inc.Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.NASDAQ:TELOTelomir Pharmaceuticals Inc
02/04/202414h30GlobeNewswire Inc.Telomir Pharmaceuticals’ Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD, to Present Promising Pre-Clinical Data for Age-Reversal Drug Telomir-1 at the National Press Club in Washington, DC, on April 15, 2024NASDAQ:TELOTelomir Pharmaceuticals Inc
29/03/202421h44GlobeNewswire Inc.UPDATE – Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in CaninesNASDAQ:TELOTelomir Pharmaceuticals Inc
26/03/202413h30GlobeNewswire Inc.Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in CaninesNASDAQ:TELOTelomir Pharmaceuticals Inc
22/03/202413h30GlobeNewswire Inc.Telomir Pharmaceuticals Releases New Pre-Clinical Data for Telomir-1 to Be Presented at the Global Longevity Federation Conference in Las Vegas on March 26thNASDAQ:TELOTelomir Pharmaceuticals Inc
14/03/202413h30GlobeNewswire Inc.Telomir Pharmaceuticals Uses AI Testing Models to Show its Lead Product Candidate’s Potential in DNA Age Reversal ScienceNASDAQ:TELOTelomir Pharmaceuticals Inc
07/03/202414h30GlobeNewswire Inc.Telomir Pharmaceuticals Presents Promising Pre-Clinical Data For Its Lead Development Product at Singapore ConferenceNASDAQ:TELOTelomir Pharmaceuticals Inc
05/03/202414h30GlobeNewswire Inc.Michael F. Roizen, MD to Increase Activities with Telomir Pharmaceuticals as Special Advisor on Age ReversalNASDAQ:TELOTelomir Pharmaceuticals Inc
13/02/202422h05GlobeNewswire Inc.Telomir Pharmaceuticals Announces Closing of Initial Public OfferingNASDAQ:TELOTelomir Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TELO

Dernières Valeurs Consultées

EU
GLE
Societe Generale
EU
ML
Michelin
EU
BN
Danone
EU
AI
Air Liquide
EU
BNP
BNP Paribas
EU
CS
Axa
COIN
ETHUSD
Ethereum
EU
RI
Pernod Ricard
COIN
AVAXUSD
Avalanche
NASDAQ
AMZN
Amazon.com
SPI
SP500
S&P 500
EU
VIV
Vivendi
NYSE
MRK
Merck
EU
SGO
Cie de SaintGobain
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces